BioSpace News Archive

Today, healthcare innovation startup, NightWare, Inc., a privately-held digital therapeutics for mental health company, has received Breakthrough Status designation from the U.S. Food and Drug Administration (FDA)

In a letter sent to healthcare providers today, the U.S. FDA validates that Abiomed’s (NASDAQ: ABMD) Impella RP heart pump is safe and effective for treatment of right heart failure.

Today the Cystic Fibrosis Foundation announced that President and CEO Preston W. Campbell, MD, plans to retire at the end of 2019.

Jack Davis, RN, ONC, manager of Patient Education and Research at Hospital for Special Surgery, has been named president of the National Association of Orthopaedic Nurses (NAON).

In an oral presentation from the Digestive Disease Week medical conference in San Diego, California today, Eli Lilly and Company (NYSE: LLY) announced new safety and efficacy data for mirikizumab in patients with moderately- to severely active Crohn’s disease.

Horizon Therapeutics plc (NASDAQ: HZNP) today announced that it has been selected to the FORTUNE and Great Place to Work® 2019 “Best Workplaces in Chicago” list

Merritt Healthcare, the industry leader in the development, management and advisory of ambulatory surgery centers (ASCs) nationwide, today announced its plan to develop a $10.2 million ASC with Mount Sinai Ambulatory Ventures, Inc., a wholly owned subsidiary of the 3,800-bed New York area-based Mount Sinai Health System.

Vascular Interventions of Tampa announced today that it will rebrand and now be known as Azura Vascular Care Tampa, a leading provider of outpatient vascular care in Hillsborough County

The College of American Pathologists (CAP) commended officials in the state of Washington for enacting law to protect patients from surprise out-of-network medical bills by banning balance billing for certain out-of-network services and requiring health insurance plans to maintain adequate networks of physicians at in-network hospitals and facilities

Medisafe, the personalized medication management platform with over five million users worldwide, announced today that further findings from its ongoing scientific study conducted by IQVIA will be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 24th Annual International Meeting in New Orleans, LA.